Facioscapulohumeral muscular dystrophy type 1A in northwestern Tuscany: A molecular genetics-based epidemiological and genotype-phenotype study

Genetic Testing

Volumn 9, Issue 1, 2005, Pages 30-36

  Sposito R ^a   Pasquali, L ^a   Galluzzi, F ^a   Rocchi, A ^a   Solito B ^a   Soragna, D ^b   Tupler, R ^b   Siciliano, G ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 4Q; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIDEMIOLOGICAL DATA; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GENE DELETION; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PHENOTYPE; POPULATION GENETICS; PREVALENCE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; CHILD; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PHENOTYPE;

EID: 17844393135     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2005.9.30     Document Type: Article

References (39)

1. ANDREW, S.E., GOLDBERG, Y.P., THEILMANN, J., et al. (1994). CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. Hum. Mol. Genet. 3, 65-67.
2. APPLETON, R.E., and NICOLAIDES, P. (1995). Early diagnosis of Duchenne muscular dystrophy. Lancet 345, 1243-1244.
3. BUTZ, M., KOCH, M.C., MULLER-FELBER, W., et al. (2003). Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers. J. Neurol. 8, 932-937.
4. CACURRI, S., DEIDDA, G., PIAZZO, N., et al. (1994). Chromosome 4q35 haplotype and DNA rearrangement segregating in affected subjects of 19 Italian families with facioscapulohumeral muscular dystrophy (FSHD). Hum. Genet. 94, 367-374.
5. CACURRI, S., PIAZZO, N., DEIDDA, G., et al. (1998). Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 63, 181-190.
6. EMERY, A.E.H. (ed.). (1994). Diagnostic Criteria for Neuromuscular Disorders. ENMC, Baarn, The Netherlands) pp. 9-13.
7. 4th ENMC International Workshop. (1998). Facioscapulohumeral muscular dystrophy: molecular studies, 19-21 July 1996, Naarden, The Netherlands. Neuromusc. Disord. 8, 126-130.
8. HEWITT, J.E., LYLE, R., CLARK, L.N., et al. (1994). Analysis of the tandem repeat locus D4Z4associated with facioscapulohumeral muscular dystrophy. Hum. Mol. Genet. 3, 1287-1295.
9. LUNT, P.W., COMPSTON, D.A., and HARPER, P.S. (1989). Estimation of age dependent penetrance in facioscapulohumeral muscular dustrophy by minimum accertainment bias. J. Med. Genet. 26, 755-760.
10. LUNT, P.W., and HARPER, P.S. (1991). Genetic counselling in facioscapulohumeral muscular dystrophy. J. Med. Genet. 28, 655-664.
11. LUNT, P.W. (1998). 44th ENMC International Workshop: Facioscapulohumeral Muscular Dystrophy: Molecular Studies 19-21 July 1996, Naarden, The Netherlands. Neuromusc. Disord. 8, 126-130.
12. MORANDI, L., MORA, M., CONFALONIERI, V., et al. (1995). Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype. J. Neurol. Sci. 132, 146-155.
13. ORRELL, R.W., TAWIL, R., FORRESTER, J., et al. (1999). Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology 52, 1822-1826.
14. PADBERG, G.W. (1982). "Facioscapulohumeral disease." Thesis. (Leiden University, Leiden, The Netherlands).
15. PADBERG, G.W., FRANTS, R.R., BROUWER, O.F., et al. (1995). Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve 2, S81-S84.
16. PASSOS-BUENO, M.R., WIJMENGA, C., TAKATA, R.E., et al. (1993). No evidence of genetic heterogeneity in Brazilian facioscapulohumeral muscular dystrophy (FSHD) with 4q markers. Hum. Mol. Genet. 2, 557-562.
17. RICCI, E., GALLUZZI, G., DEIDDA, G., et al. (1999). Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann. Neurol. 45, 751-757.
18. ROSSI, B., SICILIANO, G., SARTUCCI, F., et al. (1984). Epidemiology of progressive muscular dystrophy in northwestern Tuscany. Acta Neurolog. 39, 125-133.
19. RUBINSZTEIN, D.C., LEGGO, J., GOODBURN, S., et al. (1994). Study of the Huntington's disease (HD) gene CAG repeats in schizophrenic patients shows overlap of the normal and HD affected ranges but absence of correlation with schizophrenia. J. Med. Genet. 31, 690-693.
20. RUBINSZTEIN, D.C., LEGGO, J., COLES, R., et al. (1996). Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am. J. Hum. Genet. 59, 16-22.
21. SARFARAZI, M., WIJMENGA, C., UPADHYAYA, M., et al. (1992). Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am. J. Hum. Genet. 51, 396-403.
22. SICILIANO, G., TESSA, A., RENNA, M., et al. (1999). Epidemiology of dystrophynopaties in northwestern Tuscany: a molecular genetics-based revisitation. Clin. Genet. 56, 51-58.
23. TAWIL, R., FIGLEWICZ, D.A., GRIGGS, R.C., et al. and the FSH Consortium. (1998). Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. Ann. Neurol. 43, 279-282.
24. TAWIL, R., McDERMOTT, J.P., MENDELL, J.R., et al. (1994). Facioscapulohumeral muscular dystrophy: design of natural history study and results of baseline testing. Neurology 44, 442-446.
25. TAWIL, R., MYERS, G.J., WEIFFENBACH, B., et al. (1995). Scapuloperoneal syndromes: absence of linkage to 4q35 FSHD locus. Arch. Neurol. 52, 1069-1072.
26. TUPLER, R., and GABELLINI, D. (2004). Molecular basis of facioscapulohumeral muscular dystrophy. Cell Mol. Life Sci. 61, 557-566.
27. UPADHYAYA, M., LUNT, P., SARFARAZI, M., et al. (1992). The mapping of chromosome 4q markers in relation to facioscapulohumeral muscular dystrophy (FSHD). Am. J. Hum. Genet. 51, 404-410.
28. UPADHYAYA, M., JARDINE, P., MAYNARD, J., et al. (1993). Molecular analysis of British facioscapulohumeral muscular dystrophy families for 4q DNA rearrangements. Hum. Mol. Genet. 2, 981-987.
29. UPADHYAYA, M., MAYNARD, J., ROGERS, M.T., et al. (1999). Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD. J. Med. Genet. 34, 476-479.
30. VAN DEUTEKOM, J.C., BAKKER, E., LEMMERS, R.J., et al. (1997). Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosome 4q35 and 10q26: implications for genetic counselling and aetiology of FSHD. Hum. Mol. Genet. 5, 1997-2003.
31. VAN OVERVELD, P.G.M., LEMMERS, R., SANDKUIJL, L.A., et al. (2003). Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nature Genet. 4, 315-317.
32. VIELHABER, S., JAKUBICZKA, S., SCHRODER, J.M., et al. (2002). Facioscapulohumeral muscular dystrophy with Eco RI/BlnI fragment size of more than 32 kb. Muscle Nerve 25, 540-548.
33. VITELLI, F., VILLANOVA, M., MALANDRINI, A., et al. (1999). Inheritance of a 38 kb fragment in apparently sporadic facioscapulohumeral muscular dystrophy. Muscle Nerve 22, 1437-1441.
34. VUILLAUME, I., VERMERSCH, P., DESTEE, A., et al. (1998). Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 64, 758-762.
35. WALTON, J.N., and GARDNER-MEDWIN, D. (1974). Progressive muscular dystrophy and myotonic disorders. In: J.N. Walton (ed.). (Churchill-Livingstone, Edinburgh, London: Disorders of voluntary muscle.
36. WIJMENGA, C., HEWITT, J.E., SANDKUIJL, L.A., et al. (1992a.) Chromosome 4q DNA rearrangement associated with facioscapulohumeral muscular dystrophy. Nature Genet. 2, 26-30.
37. WIJMENGA, C., SANDKUIJL, L.A., MOERER, P., et al. (1992b). Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-ter. Am. J. Hum. Genet. 51, 411-415.
38. YAMANAKA, G., GOTO, K., ISHIHARA, T., et al. (2004). FSHD-like patients without 4q35 deletion. J. Neurol. Sci. 219, 89-93.
39. ZATZ, M., MARIE, S.K., PASSOS-BUENO, M.R., et al. (1995). High proportion of new mutation and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families. Am. J. Hum. Genet. 56, 99-105.